Omnicell Inc
Change company Symbol lookup
Select an option...
OMCL Omnicell Inc
TUES Tuesday Morning Corp
LXXGF Lexagene Holdings Inc
BKE Buckle Inc
CRMT America's CAR-MART Inc
DE Deere & Co
JKS JinkoSolar Holding Co Ltd
TLGT Teligent Inc (NEW JERSEY)
ALK Alaska Air Group Inc
AAL American Airlines Group Inc
Go

Health Care : Health Care Technology | Small Cap Growth
Company profile

Omnicell, Inc. provides automation and business analytics software solutions for patient-centric medication and supply management across the entire healthcare continuum, from the acute care hospital setting to post-acute skilled nursing and long-term care facilities to the home. It operates through two segments: Automation and Analytics, and Medication Adherence. The Automation and Analytics segment is engaged in the design, manufacturing, selling and servicing of medication and supply dispensing systems, pharmacy inventory management systems and related software. The Medication Adherence segment includes the development, manufacturing and selling of consumable medication blister cards, packaging equipment, medication synchronization platform, and ancillary products and services. Its products are used to manage medication administration outside of the hospital setting and include medication adherence products sold under the brand name MTS, Surgichem, SureMed and the Omnicell brand.

Closing Price
$65.64
Day's Change
1.11 (1.72%)
Bid
--
Ask
--
B/A Size
--
Day's High
65.79
Day's Low
64.20
Volume
(Light)
Volume:
122,454

10-day average volume:
394,865
122,454

Company Profile

Omnicell, Inc. provides automation and business analytics software solutions for patient-centric medication and supply management across the entire healthcare continuum, from the acute care hospital setting to post-acute skilled nursing and long-term care facilities to the home. It operates through two segments: Automation and Analytics, and Medication Adherence. The Automation and Analytics segment is engaged in the design, manufacturing, selling and servicing of medication and supply dispensing systems, pharmacy inventory management systems and related software. The Medication Adherence segment includes the development, manufacturing and selling of consumable medication blister cards, packaging equipment, medication synchronization platform, and ancillary products and services. Its products are used to manage medication administration outside of the hospital setting and include medication adherence products sold under the brand name MTS, Surgichem, SureMed and the Omnicell brand.

Valuation Ratios

Price/Earnings (TTM)
40.90x
Price/Sales (TTM)
3.03x
Price/Book (MRQ)
3.18x
Price/Cash Flow (TTM)
22.50x
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

Price Performance

Historic Growth and Share Detail

Historic Growth

Annual growth, past 5 years
EPS
Revenue
Dividend No Regular Dividend is paid
 

Short Interest

April 2020
Current Month
1.9M
Previous Month
1.6M
Percent of Float
4.62%
Days to Cover
7.4792 Days

Share Information

OMCL is in a share class of common stock
Float
42.1M
Shares Outstanding
42.6M
Institutions Holding Shares
397
97.96%

Financial Statements

Balance sheet

Values displayed are in millions.

Income statement

Values displayed are in millions.

Cash flow

Values displayed are in thousands.

Company Officers

  • Randall A. LippsChmn.
  • Peter J. KuipersCFO
  • Daniel S. JohnstonExec.VP
  • Nhat H. NgoExec.VP
  • Scott P. SeidelmannExec.VP

Address

Insider Trading

During the most recent quarter, 66K shares were sold in insider trading.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Insider trading information report provided by Copyright © 2020. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.